Gilead Sciences, Inc.’s (GILD) Harvoni Prescriptions Drop 1.8%

January 26, 2015 4:01 PM

3 0

Gilead saw a 1.8% week-over-week decline in the prescriptions for Harvoni while AbbVie’s Viekira Pak had an astonishing week-on-week increase of 55%, for the week ended January 16

Gilead Sciences Inc. (NASDAQ:GILD) saw a week-over-week (WoW) decline of 1.8%in prescriptions for its hepatitis C drug, Harvoni, while AbbVie Inc.’s (NYSE:ABBV) Viekira Pak had an astonishing WoW increase, for the week ended January 16. Though, the cause for these changes is not disclosed, it can be...

Read more

To category page

Loading...